The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.
Abstract Details
Activity Number:
|
484
|
Type:
|
Invited
|
Date/Time:
|
Wednesday, August 3, 2011 : 10:30 AM to 12:20 PM
|
Sponsor:
|
Section on Health Policy Statistics
|
Abstract - #300225 |
Title:
|
Visualization Tools and the Evaluation of Safety Data in Pharmaceutical Industry Clinical Trials
|
Author(s):
|
Qi Jiang*+
|
Companies:
|
Amgen Inc.
|
Address:
|
One Amgen Center Drive , Thousand Oaks, CA, 91320,
|
Keywords:
|
Safety Data ;
Clinical Trials ;
Safety Signals ;
Visualization Tools
|
Abstract:
|
Recent events have put a spotlight on the evaluation of safety data from pharmaceutical industry clinical trials. The evaluation of safety information from clinical trials has always been challenging for a number of reasons. These include the frequent lack of prespecified hypotheses, making it extremely difficult to distinguish true safety signals from spurious ones, and the fact that some events are quite rare and can only be detected in large trials of long duration. In this presentation we will discuss some proposals for addressing these problems through improved visualization tools.
|
The address information is for the authors that have a + after their name.
Authors who are presenting talks have a * after their name.
Back to the full JSM 2011 program
|
2011 JSM Online Program Home
For information, contact jsm@amstat.org or phone (888) 231-3473.
If you have questions about the Continuing Education program, please contact the Education Department.